FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304080883> ?p ?o ?g. }

• W4304080883 endingPage "154158" @default.
• W4304080883 startingPage "154158" @default.
• W4304080883 abstract "For rectal cancer patients with stage T3–4 disease or positive lymph node, neoadjuvant concurrent chemoradiotherapy (CCRT) has become the standard treatment, but the clinical outcomes are still far from satisfactory. Accordingly, a more precise predictive tool such as genetic biomarkers is urgently required to optimize therapy decisions. Colorectal cancer (CRC) development has been considerably correlated with cellular metabolic process involving nucleotides, but the underlying molecular mechanisms remain unclear. In this study, we employed a transcriptome dataset comprising 46 rectal adenocarcinoma patients undergoing preoperative CCRT and focused on nucleobase-containing compound metabolic process (GO: 0055134) for data mining. We identified solute carrier family 28 member 2 (SLC28A2) as the most considerably upregulated gene among rectal cancer patients with CCRT resistance. Afterwards, there were a total of 172 rectal cancer tissue blocks procuring from our biobank, and the immunointensity of SLC28A2 was appraised utilizing immunohistochemical staining. Strong SLC28A2 immunointensity was significantly linked to female patients (p = 0.032), vascular invasion (p = 0.021), and post-CCRT tumor invasion and regional lymph node involvement (p < 0.001 and p = 0.005). Notably, patients with strong SLC28A2 immunointensity had no tumor downstaging (p < 0.001). Univariate analysis revealed that high SLC28A2 immunoexpression was considerably unfavorably linked to all three endpoints: local recurrence-free survival (LRFS), metastasis-free survival (MeFS), and disease-specific survival (DSS) (all p ≤ 0.0333). Moreover, both high SLC28A2 immunoexpression and low tumor regression grade were independently unfavorable prognostic factors for all three endpoints (all p ≤ 0.013) in the multivariate analysis. Utilizing function prediction analysis, SLC28A2 upregulation was more likely to be linked with stem cell homeostasis in rectal cancer. In brief, we demonstrated that high SLC28A2 immunoexpression is substantially linked to an advanced stage, poor response to CCRT, and worse patient survival. Consequently, SLC28A2 expression can be a valuable predictive and prognostic marker for rectal cancer patients and be an encouraging therapeutic target for those with CCRT resistance." @default.
• W4304080883 created "2022-10-10" @default.
• W4304080883 creator A5003757557 @default.
• W4304080883 creator A5012100316 @default.
• W4304080883 creator A5017090364 @default.
• W4304080883 creator A5018449820 @default.
• W4304080883 creator A5020042657 @default.
• W4304080883 creator A5030184709 @default.
• W4304080883 creator A5044356712 @default.
• W4304080883 creator A5057101844 @default.
• W4304080883 creator A5067678358 @default.
• W4304080883 creator A5070326975 @default.
• W4304080883 creator A5071433972 @default.
• W4304080883 creator A5078966533 @default.
• W4304080883 creator A5089774691 @default.
• W4304080883 date "2022-11-01" @default.
• W4304080883 modified "2023-10-01" @default.
• W4304080883 title "High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT" @default.
• W4304080883 cites W115576981 @default.
• W4304080883 cites W1969984411 @default.
• W4304080883 cites W2017436645 @default.
• W4304080883 cites W2018189509 @default.
• W4304080883 cites W205942636 @default.
• W4304080883 cites W2061147784 @default.
• W4304080883 cites W2079210215 @default.
• W4304080883 cites W2100241851 @default.
• W4304080883 cites W2113353705 @default.
• W4304080883 cites W2124695217 @default.
• W4304080883 cites W2125452425 @default.
• W4304080883 cites W2804640180 @default.
• W4304080883 cites W2807152078 @default.
• W4304080883 cites W2883340853 @default.
• W4304080883 cites W2968149989 @default.
• W4304080883 cites W2974834475 @default.
• W4304080883 cites W2980079090 @default.
• W4304080883 cites W2980518880 @default.
• W4304080883 cites W2994080338 @default.
• W4304080883 cites W3022515873 @default.
• W4304080883 cites W3033624893 @default.
• W4304080883 cites W3044355943 @default.
• W4304080883 cites W3046245082 @default.
• W4304080883 cites W3048741892 @default.
• W4304080883 cites W3092277280 @default.
• W4304080883 cites W3126855374 @default.
• W4304080883 cites W3135750665 @default.
• W4304080883 cites W3197422567 @default.
• W4304080883 cites W3201846784 @default.
• W4304080883 cites W3202722142 @default.
• W4304080883 doi "https://doi.org/10.1016/j.prp.2022.154158" @default.
• W4304080883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36244249" @default.
• W4304080883 hasPublicationYear "2022" @default.
• W4304080883 type Work @default.
• W4304080883 citedByCount "1" @default.
• W4304080883 countsByYear W43040808832023 @default.
• W4304080883 crossrefType "journal-article" @default.
• W4304080883 hasAuthorship W4304080883A5003757557 @default.
• W4304080883 hasAuthorship W4304080883A5012100316 @default.
• W4304080883 hasAuthorship W4304080883A5017090364 @default.
• W4304080883 hasAuthorship W4304080883A5018449820 @default.
• W4304080883 hasAuthorship W4304080883A5020042657 @default.
• W4304080883 hasAuthorship W4304080883A5030184709 @default.
• W4304080883 hasAuthorship W4304080883A5044356712 @default.
• W4304080883 hasAuthorship W4304080883A5057101844 @default.
• W4304080883 hasAuthorship W4304080883A5067678358 @default.
• W4304080883 hasAuthorship W4304080883A5070326975 @default.
• W4304080883 hasAuthorship W4304080883A5071433972 @default.
• W4304080883 hasAuthorship W4304080883A5078966533 @default.
• W4304080883 hasAuthorship W4304080883A5089774691 @default.
• W4304080883 hasBestOaLocation W43040808831 @default.
• W4304080883 hasConcept C121608353 @default.
• W4304080883 hasConcept C126322002 @default.
• W4304080883 hasConcept C143998085 @default.
• W4304080883 hasConcept C144301174 @default.
• W4304080883 hasConcept C2778292576 @default.
• W4304080883 hasConcept C2778424827 @default.
• W4304080883 hasConcept C2780849966 @default.
• W4304080883 hasConcept C38180746 @default.
• W4304080883 hasConcept C526805850 @default.
• W4304080883 hasConcept C530470458 @default.
• W4304080883 hasConcept C71924100 @default.
• W4304080883 hasConceptScore W4304080883C121608353 @default.
• W4304080883 hasConceptScore W4304080883C126322002 @default.
• W4304080883 hasConceptScore W4304080883C143998085 @default.
• W4304080883 hasConceptScore W4304080883C144301174 @default.
• W4304080883 hasConceptScore W4304080883C2778292576 @default.
• W4304080883 hasConceptScore W4304080883C2778424827 @default.
• W4304080883 hasConceptScore W4304080883C2780849966 @default.
• W4304080883 hasConceptScore W4304080883C38180746 @default.
• W4304080883 hasConceptScore W4304080883C526805850 @default.
• W4304080883 hasConceptScore W4304080883C530470458 @default.
• W4304080883 hasConceptScore W4304080883C71924100 @default.
• W4304080883 hasLocation W43040808831 @default.
• W4304080883 hasLocation W43040808832 @default.
• W4304080883 hasOpenAccess W4304080883 @default.
• W4304080883 hasPrimaryLocation W43040808831 @default.
• W4304080883 hasRelatedWork W2141932391 @default.
• W4304080883 hasRelatedWork W2249625608 @default.
• W4304080883 hasRelatedWork W2328762932 @default.

• next